[HTML][HTML] Análisis de la incidencia y de las características clínicas de las reacciones adversas a medicamentos de uso humano en el medio hospitalario

…, C Navarro Pemán, F González Rubio… - Revista Española de …, 2017 - SciELO Espana
Métodos: Estudio observacional y prospectivo de monitorización intensiva de RAM de los
pacientes ingresados en los servicios de Medicina Interna en un hospital de tercer nivel …

[HTML][HTML] Deprescribiendo para mejorar la salud de las personas o cuando deprescribir puede ser la mejor medicina

ÓE Jiménez, MPA Aniés, CV Caldentey, FG Rubio… - Atención Primaria, 2018 - Elsevier
La creciente longevidad de la población, el aumento de la morbilidad y del consumo de
medicamentos han provocado que la polimedicación sea un problema de salud prioritario por …

[HTML][HTML] Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis

…, LA Gimeno-Feliu, F González-Rubio… - PloS one, 2012 - journals.plos.org
Objectives The primary objective of this study was to identify the existence of chronic disease
multimorbidity patterns in the primary care population, describing their clinical components …

Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

…, B Poblador-Plou, F González-Rubio… - British Journal of …, 2012 - bjgp.org
Background The consequences of multimorbidity include polypharmacy and repeated referrals
for specialised care, which may increase the risk of adverse drug events (ADEs). Aim The …

[HTML][HTML] Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain

…, LA Gimeno-Feliú, F González-Rubio… - International journal of …, 2020 - mdpi.com
We aimed to analyze baseline socio-demographic and clinical factors associated with an
increased likelihood of mortality in men and women with coronavirus disease (COVID-19). We …

[HTML][HTML] Association between physical activity, multimorbidity, self-rated health and functional limitation in the Spanish population

…, B Poblador-Plou, F González-Rubio… - BMC public health, 2014 - Springer
Background Physical activity (PA) has been shown to improve the general health of patients
with chronic diseases and to prevent the onset of such conditions. However, the association …

[HTML][HTML] Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based …

…, J Carmona-Pírez, A Poncel-Falcó, F González-Rubio… - PloS one, 2021 - journals.plos.org
Background Clinical outcomes among COVID-19 patients vary greatly with age and underlying
comorbidities. We aimed to determine the demographic and clinical factors, particularly …

Evolution of polypharmacy in a spanish population (2005‐2015): A database study

…, F GonzálezRubio… - … and Drug Safety, 2020 - Wiley Online Library
Purpose To analyze the evolution of the prevalence of polypharmacy and excessive
polypharmacy in a Spanish population, and to improve the identification of patients with …

Adherence to chronic medication in older populations: Application of a common protocol among three European cohorts

…, S Malo, E Costa, F González-Rubio… - Patient preference …, 2018 - Taylor & Francis
Purpose The purpose of this study was to evaluate and compare medication adherence to
chronic therapies in older populations across different regions in Europe. Methods This …

[HTML][HTML] Polypharmacy patterns: unravelling systematic associations between prescribed medications

…, LA Gimeno-Feliu, F González-Rubio… - PLoS …, 2013 - journals.plos.org
Objectives The aim of this study was to demonstrate the existence of systematic associations
in drug prescription that lead to the establishment of patterns of polypharmacy, and the …